SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-197309
Filing Date
2021-06-23
Accepted
2021-06-23 16:30:55
Documents
12
Period of Report
2021-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A d148799d8ka.htm   iXBRL 8-K/A 26853
  Complete submission text file 0001193125-21-197309.txt   152549

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clvs-20210610.xsd EX-101.SCH 2533
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20210610_lab.xml EX-101.LAB 18674
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20210610_pre.xml EX-101.PRE 11682
5 EXTRACTED XBRL INSTANCE DOCUMENT d148799d8ka_htm.xml XML 4129
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35347 | Film No.: 211039016
SIC: 2834 Pharmaceutical Preparations